The director of melanoma research within the Northwestern Skin Cancer Institute presented his validation study at a meeting of the American Academy of Dermatology.
Browsing: Clinical Breakthroughs
Northwestern Medicine, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with the goal of providing clear instructions on prescription medicine labels so patients don’t make mistakes.
A new intravaginal ring filled with an anti-retroviral drug demonstrated a 100 percent success rate protecting primates from the simian human immunodeficiency virus (SHIV).
Preliminary findings from a study by scientists at Feinberg and Vanderbilt University have shown no evidence of underlying coronary artery disease in some patients.
Mary McDermott, MD, professor in general internal medicine and geriatrics and preventive medicine, recently published a study in JAMA that may change clinical guidelines for patients with peripheral artery disease (PAD).
The Research on Adverse Drug Events and Reports project issued reports on 33 serious adverse drug or device reactions in its first decade of existence, showing its value as an independent drug surveillance program.
New study finds that murderers who kill impulsively, often out of rage, and those who carefully carry out premeditated crimes differ markedly both psychologically and intellectually.
More suspected stroke victims received emergency care and potentially life-saving treatments in Chicago’s stroke centers thanks to a 2011 policy change under the Illinois Primary Stroke Center Act.
In 2020, the majority of adults in America will be overweight or obese and more than half will suffer from diabetes or pre-diabetic conditions, according to projections presented today by Northwestern Medicine researchers at the AHA Scientific Sessions.